SelectivePPARδantagonist(IC50valuesare0.155,>10and≥10μMatPPARδ,PPARαandPPARγrespectively).Exhibitsinverseagonisteffectswhenadministeredbyitself.
GSK0660isalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
M.Wt | 418.49 |
Formula | C19H18N2O5S2 |
Storage | Storeat+4°C |
Purity | ≥99%(HPLC) |
CASNumber | 1014691-61-2 |
PubChemID | 46233311 |
InChIKey | NDFKBGWLUHKMFY-UHFFFAOYSA-N |
Smiles | O=S(NC1=C(OC)C=C(NC3=CC=CC=C3)C=C1)(C2=C(C(OC)=O)SC=C2)=O |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Solvent | MaxConc.mg/mL | MaxConc.mM | |
---|---|---|---|
Solubility | |||
DMSO | 41.85 | 100 | |
ethanol | 4.18 | 10 |
Thefollowingdataisbasedontheproductmolecularweight418.49.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
---|---|---|---|
1mM | 2.39mL | 11.95mL | 23.9mL |
5mM | 0.48mL | 2.39mL | 4.78mL |
10mM | 0.24mL | 1.19mL | 2.39mL |
50mM | 0.05mL | 0.24mL | 0.48mL |